Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L
PHASE1Active, not recruitingINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
October 22, 2024
Primary Completion Date
May 15, 2026
Study Completion Date
May 15, 2026
Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL
ANT-301
Administration on Day 1
Trial Locations (1)
03080
Seoul National University, Seoul
All Listed Sponsors
lead
Anterogen Co., Ltd.
INDUSTRY
NCT06539429 - Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L | Biotech Hunter | Biotech Hunter